Search research articles
Contact Us
Filters
Showing results (471-480 of 506) with videos related to
Page
of 51
Sort By:
Developmental Cell
|
September 23, 2020
A Membrane-Tethered Ubiquitination Pathway Regulates Hedgehog Signaling and Heart Development
Jennifer H Kong, Cullen B Young, Ganesh V Pusapati, et al.
Science Translational Medicine
|
March 22, 2023
Antibody-mediated protection against symptomatic COVID-19 can be achieved at low serum neutralizing titers
Pete Schmidt, Kristin Narayan, Yong Li, et al.
Cell Reports
|
April 16, 2023
Antibodies against the Ebola virus soluble glycoprotein are associated with long-term vaccine-mediated protection of non-human primates
Bronwyn M Gunn, Ryan P McNamara, Lianna Wood, et al.
Communications Biology
|
July 31, 2024
Author Correction: Antibodies targeting the glycan cap of Ebola virus glycoprotein are potent inducers of the complement system
Philipp A Ilinykh, Kai Huang, Bronwyn M Gunn, et al.
The Journal of Infectious Diseases
|
July 14, 2019
Survivors of Ebola Virus Disease Develop Polyfunctional Antibody Responses
Bronwyn M Gunn, Vicky Roy, Marcus M Karim, et al.
Communications Biology
|
July 17, 2024
Antibodies targeting the glycan cap of Ebola virus glycoprotein are potent inducers of the complement system
Philipp A Ilinykh, Kai Huang, Bronwyn M Gunn, et al.
Journal of Virology
|
December 7, 2018
Antibody-Mediated Protective Mechanisms Induced by a Trivalent Parainfluenza Virus-Vectored Ebolavirus Vaccine
J Brian Kimble, Delphine C Malherbe, Michelle Meyer, et al.
Contemporary Clinical Trials
|
September 15, 2020
The assertive cardiac care trial: A randomised controlled trial of a coproduced assertive cardiac care intervention to reduce absolute cardiovascular disease risk in people with severe mental illness in the primary care setting
Matthew Lewis, Patty Chondros, Cathrine Mihalopoulos, et al.
The FEBS Journal
|
June 25, 2009
The novel molecule 2-[5-(2-chloroethyl)-2-acetoxy-benzyl]-4-(2-chloroethyl)-phenyl acetate inhibits phosphoinositide 3-kinase/Akt/mammalian target of rapamycin signalling through JNK activation in cancer cells
Ka-Kei Ho, Evelyn Rosivatz, Richard M Gunn, et al.
Frontiers in Immunology
|
June 7, 2021
Associations Between Antibody Fc-Mediated Effector Functions and Long-Term Sequelae in Ebola Virus Survivors
Dominic Paquin-Proulx, Bronwyn M Gunn, Aljawharah Alrubayyi, et al.
Page
of 51
Search research articles
Search
Showing results (471-480 of 506) with videos related to
Sort By:
Page
of 51
Developmental Cell
|
September 23, 2020
A Membrane-Tethered Ubiquitination Pathway Regulates Hedgehog Signaling and Heart Development
Jennifer H Kong, Cullen B Young, Ganesh V Pusapati, et al.
Science Translational Medicine
|
March 22, 2023
Antibody-mediated protection against symptomatic COVID-19 can be achieved at low serum neutralizing titers
Pete Schmidt, Kristin Narayan, Yong Li, et al.
Cell Reports
|
April 16, 2023
Antibodies against the Ebola virus soluble glycoprotein are associated with long-term vaccine-mediated protection of non-human primates
Bronwyn M Gunn, Ryan P McNamara, Lianna Wood, et al.
Communications Biology
|
July 31, 2024
Author Correction: Antibodies targeting the glycan cap of Ebola virus glycoprotein are potent inducers of the complement system
Philipp A Ilinykh, Kai Huang, Bronwyn M Gunn, et al.
The Journal of Infectious Diseases
|
July 14, 2019
Survivors of Ebola Virus Disease Develop Polyfunctional Antibody Responses
Bronwyn M Gunn, Vicky Roy, Marcus M Karim, et al.
Communications Biology
|
July 17, 2024
Antibodies targeting the glycan cap of Ebola virus glycoprotein are potent inducers of the complement system
Philipp A Ilinykh, Kai Huang, Bronwyn M Gunn, et al.
Journal of Virology
|
December 7, 2018
Antibody-Mediated Protective Mechanisms Induced by a Trivalent Parainfluenza Virus-Vectored Ebolavirus Vaccine
J Brian Kimble, Delphine C Malherbe, Michelle Meyer, et al.
Contemporary Clinical Trials
|
September 15, 2020
The assertive cardiac care trial: A randomised controlled trial of a coproduced assertive cardiac care intervention to reduce absolute cardiovascular disease risk in people with severe mental illness in the primary care setting
Matthew Lewis, Patty Chondros, Cathrine Mihalopoulos, et al.
The FEBS Journal
|
June 25, 2009
The novel molecule 2-[5-(2-chloroethyl)-2-acetoxy-benzyl]-4-(2-chloroethyl)-phenyl acetate inhibits phosphoinositide 3-kinase/Akt/mammalian target of rapamycin signalling through JNK activation in cancer cells
Ka-Kei Ho, Evelyn Rosivatz, Richard M Gunn, et al.
Frontiers in Immunology
|
June 7, 2021
Associations Between Antibody Fc-Mediated Effector Functions and Long-Term Sequelae in Ebola Virus Survivors
Dominic Paquin-Proulx, Bronwyn M Gunn, Aljawharah Alrubayyi, et al.
Page
of 51